2023-2024 Regular Session • US Congress Legislature
HB5575: Safe Medicine Act
Legislative Summary
To direct the Secretaries of Health and Human Services, Defense, and Veterans Affairs to end American over-dependence on Chinese pharmaceuticals by encouraging the growth of a robust domestic medicine supply chain for generic drugs, to empower the Food and Drug Administration to issue boxed warnings in the case of critical contamination, and for other purposes.
Bill History
9/19/2023
Introduced in House
House of Representatives
9/19/2023
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Armed Services, Veterans' Affairs, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
House of Representatives
9/22/2023
Referred to the Subcommittee on Health.
House of Representatives
12/17/2024
Referred to the Subcommittee on Trade.
House of Representatives
12/17/2024
Referred to the Subcommittee on Health.
House of Representatives
Status Information
Current Status
Introduced(9/19/2023)
Chamber
House of Representatives
Committee
Subcommittee on Health(House of Representatives)
Sponsors
Republican: 1
Primary Sponsor
Bill Posey
Republican